๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The objective of this study is to determine the effect of two dose strength...
Status
Completed
Location
Acorda Site #117
Start Date
2014-12
Trial ID
NCT02271217
Treatments Being Tested
The purpose of this study is to investigate the pharmacokinetics of single ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-12
Trial ID
NCT01250730
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of a lo...
Status
Completed
Location
North Central Neurology Associates, PC
Start Date
2011-03
Trial ID
NCT01328379
Treatments Being Tested
This study evaluates the effects of sustained-release oral dalfampridine in...
Status
Unknown
Location
Multiple Sclerosis Center
Start Date
2014-11
Trial ID
NCT02259361
Treatments Being Tested
The purpose of this study is to see if the study drug 4-aminopyridine (4-AP...
Status
Withdrawn
Location
University of Rochester Medical Center
Start Date
2018-10-03
Trial ID
NCT03658408
Treatments Being Tested
Cognitive impairment is common in multiple sclerosis (MS) and has devastati...
Status
Completed
Location
Buffalo General Hospital
Start Date
2011-12
Trial ID
NCT02006160
Treatments Being Tested
Fampyra, a voltage-dependent potassium channel blocker, is indicated for th...
Status
Completed
Location
ฮiginitio hospital
Start Date
2017-03-07
Trial ID
NCT03164018
Treatments Being Tested
The study investigators are interested in learning more about how drugs, th...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2020-03-05
Trial ID
NCT04278404
The goal of this interventional double blind, randomized placebo controlled...
Status
Completed
Location
Multiple Locations
Start Date
2011-07-13
Trial ID
NCT05859802
Treatments Being Tested